Brian L McClune

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. doi request reprint Osteoporosis after stem cell transplantation
    Brian L McClune
    Division of Hematology, Oncology and Transplantation, University of Minnesota, 420 Delaware St, SE, Minneapolis, MN, 55455, USA
    Curr Osteoporos Rep 11:305-10. 2013
  2. doi request reprint Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care?
    Brian L McClune
    University of Minnesota, Minneapolis, Minnesota, USA
    Curr Opin Hematol 17:133-8. 2010
  3. pmc Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome
    Brian L McClune
    DO, University of Minnesota, Division of Hematology, Oncology and Transplantation, University of Minnesota, MMC 480, 420 Delaware St SE, Minneapolis, MN 55455, USA
    J Clin Oncol 28:1878-87. 2010

Detail Information

Publications3

  1. doi request reprint Osteoporosis after stem cell transplantation
    Brian L McClune
    Division of Hematology, Oncology and Transplantation, University of Minnesota, 420 Delaware St, SE, Minneapolis, MN, 55455, USA
    Curr Osteoporos Rep 11:305-10. 2013
    ..In this review, we highlight the major pathological mechanisms behind the development of OP, its diagnosis, and the literature supporting consensus treatment recommendations while noting areas of uncertainty that need further research. ..
  2. doi request reprint Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care?
    Brian L McClune
    University of Minnesota, Minneapolis, Minnesota, USA
    Curr Opin Hematol 17:133-8. 2010
    ..We reviewed reduced-intensity hematopoietic cell transplantation for older patients in the context of recently published studies...
  3. pmc Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome
    Brian L McClune
    DO, University of Minnesota, Division of Hematology, Oncology and Transplantation, University of Minnesota, MMC 480, 420 Delaware St SE, Minneapolis, MN 55455, USA
    J Clin Oncol 28:1878-87. 2010
    ..Better pre-HCT performance status predicted improved 2-year OS. CONCLUSION With these similar outcomes observed in older patients, we conclude that older age alone should not be considered a contraindication to HCT...